Case Report: Long-Term Survival With Anlotinib in a Patient With Advanced Undifferentiated Large-Cell Lung Cancer and Rare Tonsillar Metastasis

Case Report: Long-Term Survival With Anlotinib in a Patient With Advanced Undifferentiated Large-Cell Lung Cancer and Rare Tonsillar Metastasis

Undifferentiated large-cell lung cancer is a rare type of non-small cell lung cancer (NSCLC) with a poor prognosis. It is insensitive to chemotherapy and easily develops drug resistance. Analysis of the Surveillance, Epidemiology, and End Results (SEER) database showed that patients with stage IV un...

Full description

Bibliographic Details
Main Authors: Tianwei Xu, Chenchen Wei, Xiaoteng Zou, Binbin Lu, Zhaoxia Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Oncology
Subjects:
undifferentiated large-cell lung cancer
antiangiogenic therapy
anlotinib
tonsillar metastasis
platelet-derived growth factor receptors (PDGFR)
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.680818/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.680818/full

Similar Items